Sign Out
Genotropin should not be used when there is any evidence of activity of a tumor.
Intracranial lesions must be inactive and antitumor therapy completed prior to the institution of therapy.
Genotropin should be discontinued if there is evidence of tumor growth.
Patients with closed epiphysis and known hypersensitivity to m-cresol.
Acute catabolism, including pre- and postoperative treatment, critically ill patients and burn patients.
